Compagnie Lombard Odier S Cm A Gsk PLC Transaction History

Compagnie Lombard Odier S Cm A

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 28, 2021	SELL	$38.79 - $43.16 $15,516 - $17,264	-400 Reduced 36.36%	700 $27,000
Q2 2020 Aug 14, 2020	SELL	$37.87 - $43.58 $170,415 - $196,110	-4,500 Reduced 80.36%	1,100 $45,000
Q1 2020 May 13, 2020	BUY	$32.47 - $48.83 $35,717 - $53,713	1,100 Added 24.44%	5,600 $213,000
Q4 2019 Feb 13, 2020	SELL	$42.0 - $48.25 $189,000 - $217,125	-4,500 Reduced 50.0%	4,500 $211,000
Q1 2019 May 13, 2019	SELL	$38.57 - $42.69 $134,995 - $149,415	-3,500 Reduced 28.0%	9,000 $376,000
Q3 2018 Nov 13, 2018	SELL	$39.75 - $42.69 $139,125 - $149,415	-3,500 Reduced 21.88%	12,500 $503,000
Q1 2018 May 11, 2018	BUY	$36.18 - $40.15 $253,260 - $281,050	7,000 Added 77.78%	16,000 $625,000
Q3 2017 Nov 14, 2017	SELL	$39.44 - $41.55 $3,273 - $3,448	-83 Reduced 0.91%	9,000 $365,000
Q2 2017 Aug 14, 2017	BUY	N/A	9,083	9,083 $392,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.